Abstracts

Persistence of SARS-CoV-2 in Platelets and Megakaryocytes in Long COVID

Background: We have shown that acute COVID-19 pathophysiology is profoundly altered by infection of lung megakaryocytes (MKs) and platelets by SARS‑CoV‑2 (Zhu et al, 2022). A significant proportion of COVID-19 patients have symptoms persisting for > 3 months after initial infection with SARS-CoV-2, referred to as Long COVID or Post-acute Sequelae of SARS-CoV-2 (PASC) patients.…

The Opioid Use Disorder Care Cascade for PWH Experiencing Homelessness in Low-Barrier HIV Care

Background: Among people with HIV (PWH) with co-morbid opioid use disorder (OUD), initiation and retention in OUD treatment (e.g., buprenorphine, methadone) substantially reduces overdose deaths and improves HIV viral suppression. We sought to characterize the OUD care cascade for viremic PWH experiencing homelessness enrolled in a low-barrier HIV primary care model with embedded addiction support…

Emerging Integrase Resistance in the Perinatal Virtual Clinic: The Need for Protease Inhibitors

Background: The perinatal virtual clinic (PVC); a monthly multidisciplinary forum reviews complex management decisions for children and adolescents living with HIV (CALWHIV) referred from high (HIC) and low/middle income countries (L/MIC). We investigated the prevalence of emergent integrase drug resistance mutations (INSTI-DRMs) necessitating protease inhibitor (PI) based regimens. Methods: Review of 5 years of PVC…

Antagonism of Viral Glycoproteins by Guanylate Binding Protein 5

Background: Guanylate binding protein (GBP) 5 is an interferon-inducible cellular factor with broad antiviral activity, reducing the infectivity of progeny virions by interfering with processing and incorporation of viral glycoproteins. GBP5 is believed to inhibit the infectivity of HIV-1, highly pathogenic influenza A, and dengue virus by reducing the proteolytic activity of furin. However, the…

Increased Viral Suppression With Adherence Counseling Incorporating a Point-of-Care Urine TFV Test

Background: Innovative approaches are needed to achieve the third UNAIDS 95-95-95 target, to increase and sustain virologic suppression (VS) in patients on ART, specifically co-formulated tenofovir (TFV)-lamivudine-dolutegravir (DTG) or TLD. Virologic failure in patients on TLD is likely due to non-adherence because of DTG’s high resistance barrier. Identifying non-adherence to TLD with a point-of-care (POC)…

PrEP Non-Persistence and New HIV Diagnoses: A Real-World Analysis of >120,000 People Prescribed PrEP

Background: HIV pre-exposure prophylaxis (PrEP) uptake has increased, but discontinuation and inconsistent use (referred to here as non-persistence) remain common. The impact of PrEP non-persistence on new HIV infections at the population level is not well characterized. In this study, we leveraged a large real-world dataset in the United States to evaluate the impact of…

Increased Viral Suppression With Adherence Counseling Incorporating a Point-of-Care Urine TFV Test

Background: Innovative approaches are needed to achieve the third UNAIDS 95-95-95 target, to increase and sustain virologic suppression (VS) in patients on ART, specifically co-formulated tenofovir (TFV)-lamivudine-dolutegravir (DTG) or TLD. Virologic failure in patients on TLD is likely due to non-adherence because of DTG’s high resistance barrier. Identifying non-adherence to TLD with a point-of-care (POC)…